Atlas Trials

A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

Clinical trial NCT00993018 · TERMINATED

Trial details

NCT number
NCT00993018
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathy
Start date
2009-11-01
Primary completion
2011-06-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.